Publications (48) PEDRO MANUEL SÁNCHEZ GÓMEZ publications

2024

  1. As We Were and as We Should Be, Combined Exercise Training in Adults with Schizophrenia: CORTEX-SP Study Part I

    Medicine and Science in Sports and Exercise, Vol. 56, Núm. 1, pp. 73-81

  2. Functioning in schizophrenia: Recommendations of an expert panel

    Schizophrenia Research, Vol. 270, pp. 317-322

2023

  1. Analyzing structural and functional brain changes related to an integrative cognitive remediation program for schizophrenia: A randomized controlled trial

    Schizophrenia Research, Vol. 255, pp. 82-92

  2. Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies

    Annals of General Psychiatry, Vol. 22, Núm. 1

  3. Moderators of functional improvement after integrative cognitive remediation in schizophrenia: Toward a personalized treatment approach

    Psychiatry Research, Vol. 329

2021

  1. Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia

    Psychiatry Research, Vol. 295

  2. Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial

    npj Schizophrenia, Vol. 7, Núm. 1

  3. Cross-validation of predictive equation for cardiorespiratory fitness by modified shuttle walk test in adults with schizophrenia: A secondary analysis of the cortex-sp study

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 21

  4. The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia

    BMC Psychiatry, Vol. 21, Núm. 1

  5. The impact of creativity on functional outcome in schizophrenia: a mediational model

    npj Schizophrenia, Vol. 7, Núm. 1

2020

  1. Brain White Matter Correlates of Creativity in Schizophrenia: A Diffusion Tensor Imaging Study

    Frontiers in Neuroscience, Vol. 14

  2. Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks’ treatment in patients with clinically stable schizophrenia

    Neuropsychiatric Disease and Treatment, Vol. 16, pp. 3197-3208

  3. Effect of psychiatric symptoms and quality of life on cognitive performance in HCV patients

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 1, pp. 22-30

  4. Mediating role of cognition and social cognition on creativity among patients with schizophrenia and healthy controls: Revisiting the Shared Vulnerability Model

    Psychiatry and Clinical Neurosciences, Vol. 74, Núm. 2, pp. 149-155

  5. Neurocognitive, social cognitive, and clinical predictors of creativity in schizophrenia

    Journal of Psychiatric Research, Vol. 129, pp. 206-213

2019

  1. An outcome prediction model for schizophrenia: A structural equation modelling approach

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 4, pp. 232-241

2018

  1. Functional recovery in patients with schizophrenia: Recommendations from a panel of experts

    BMC Psychiatry, Vol. 18, Núm. 1

  2. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia

    Journal of Psychiatric Research, Vol. 101, pp. 21-27

  3. Neuropsicología de la esquizofrenia

    Síntesis

2016

  1. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: A randomized controlled trial

    npj Schizophrenia, Vol. 2